GlobeNewswire Inc.··NaMBX Biosciences Grants $4.2M Options Package to New Chief Business Officer
MBX Biosciences grants new Chief Business Officer Karen Basbaum 130,000 stock options worth ~$4.2M as inducement award under Nasdaq regulations.
MBXPhase 3 trialstock options